SCHEMBL25707280

SCHEMBL25707280

CCOC(=O)/C=C/c1cc(C)nc(C)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 1/20 0.47
▸ DPP4 P27487 1/20 0.47
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA7 P43166 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ CA14 Q9ULX7 1/20 0.46
▸ CYP3A4 P08684 2/20 0.44
▸ MAOB P27338 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ FDPS P14324 1/20 0.41
▸ HCAR2 Q8TDS4 1/20 0.41
▸ P2RY12 Q9H244 1/20 0.40
▸ CCNC P24863 1/20 0.40
▸ CDK8 P49336 1/20 0.40
▸ CNKSR1 Q969H4 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30404055 1.00 TTR (0.47) TTRDPP4CA12CA1CA2
SCHEMBL25177052 0.78 ALDH1A1 (0.45) TTRDPP4CA12CA1CA2
SCHEMBL25706837 0.77 CA12 (0.49) TTRDPP4CA12CA1CA2
SCHEMBL2302950 0.75 CA12 (0.50) TTRDPP4CA12CA1CA2
SCHEMBL2302954 0.75 CA12 (0.50) TTRDPP4CA12CA1CA2
SCHEMBL20223478 0.74 TTR (0.43) TTRDPP4CA12CA1CA2
SCHEMBL30036780 0.74 TTR (0.43) TTRDPP4CA12CA1CA2
SCHEMBL24844820 0.73 CA12 (0.51) TTRDPP4CA12CA1CA2
SCHEMBL9331716 0.72 HDAC1 (0.47) TTRDPP4CA12CA1CA2
SCHEMBL23174788 0.72 TTR (0.47) TTRDPP4CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150394-A1 METHODS FOR TREATMENT OF CANCER FRONTIER MEDICINES CORPORATION (US) 2023-08-10 — — WO disclosed
WO-2023081840-A1 KRAS G12C INHIBITORS FRONTIER MEDICINES CORPORATION (US) 2023-05-11 — — WO disclosed
Send feedback